Science Explorer Back to mapMap
Discussion
Company · Waltham · United States

TScan Therapeutics (United States)

tscan.comROR OpenAlex
Research works
22
▲ 215% vs 2018-21
Citations
333
15.0 per fractional work
Top-10% rate
8.2%
all institutions 10.0%
Open access
68%
world 40%
International
11%
world 18%
TScan Therapeutics (United States)

Not ranked overall: TScan Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does TScan Therapeutics (United States) work in?

In all years, 63% of research at TScan Therapeutics (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (63%), Immunology and Microbiology (21%), Biochemistry, Genetics and Molecular Biology (15%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 14 fractional works · 63.3% of its workMedicine: 14 fractional works · 63.3% of its workOncology: 10 fractional works · 44.2% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 5.8% of its workImmunology and Allergy: 0 fractional works · 2.1% of its workInfectious Diseases: 0 fractional works · 2.0% of its workHematology: 0 fractional works · 1.7% of its workEpidemiology: 0 fractional works · 1.1% of its workPhysiology: 0 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.8% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workTransplantation: 0 fractional works · 0.7% of its workRheumatology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workReproductive Medicine: 0 fractional works · 0.2% of its workLife Sciences: 8 fractional works · 36.2% of its workImmunology and Microbiology: 5 fractional works · 20.9% of its workImmunology: 5 fractional works · 20.9% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 14.9% of its workMolecular Biology: 3 fractional works · 11.7% of its workGenetics: 1 fractional works · 2.5% of its workBiotechnology: 0 fractional works · 0.3% of its workCancer Research: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workPhysical Sciences: 0 fractional works · 0.5% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.0% of its workALL ITS WORKTScanTherapeutics…22fractional works, all years
Life Sciences36%Physical Sciences1%Health Sciences63%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Medicine1463.3%
    1. Immunology and Microbiology520.9%
    2. Biochemistry, Genetics and Molecular Biology314.9%
    3. Neuroscience00.4%
    1. Mathematics00.3%
    2. Engineering00.2%
    3. Chemistry00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at TScan Therapeutics (United States)?

Ranked on the quality score, Cagan Gurer, Nancy H. Nabilsi and Andrew P. Ferretti lead among researchers whose main affiliation is TScan Therapeutics (United States).

  1. 1 Cagan Gurer United States · #284,553 worldwide 2.8k citations · 42 works
  2. 2 Nancy H. Nabilsi United States · #855,712 worldwide 1.5k citations · 36 works
  3. 3 Andrew P. Ferretti United States · #1,398,161 worldwide 1.1k citations · 19 works
  4. 4 Alexander W. Cristofaro United States · #1,663,884 worldwide 574 citations · 15 works
  5. 5 Jenny Tadros United States · #1,700,222 worldwide 725 citations · 33 works
  6. 6 Antoine J Boudot United States · #1,984,623 worldwide 355 citations · 31 works
All ranked researchers at TScan Therapeutics (United States)

What are the most cited papers from TScan Therapeutics (United States)?

The most cited paper from TScan Therapeutics (United States) is "Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma" (Giacomo Oliveira et al., 2021), with 584 citations. Next come "Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy" (399) and "Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein" (367).

Most cited papers
#PaperReleasedCitations
1 Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma Giacomo Oliveira et al. · Nature Open access 21 Jul 2021 584
2 Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy Adrienne Luoma et al. · Cell Open access 7 Jul 2022 399
3 Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein Andrew P. Ferretti, Tomasz Kula, Yifan Wang et al. · Immunity Open access 20 Oct 2020 367
4 Development of spirulina for the manufacture and oral delivery of protein therapeutics Benjamin W. Jester et al. · Nature Biotechnology Open access 21 Mar 2022 126
5 Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine Apostolia Maria Tsimberidou, David S. Hong, Jennifer J. Wheler et al. · Journal of Hematology & Oncology Open access Dec 2019 82
All 23 most cited papers, with filters and sorting

Which keywords describe research at TScan Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, CAR T Cells, Chimeric Antigen Receptor, Antigen Presentation, Immunity and Dendritic Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 14 words, with their numbers
  1. Cancer Immunotherapy13▲ 404×2 topics
  2. Immunotherapy9▲ 65×3 topics
  3. CAR T Cells9▲ 961×1 topic
  4. Chimeric Antigen Receptor9▲ 961×1 topic
  5. Tumor Regression9▲ 480×2 topics
  6. Antigen Presentation4▲ 170×2 topics
  7. Immunity4▲ 49×2 topics
  8. Dendritic Cells3▲ 129×1 topic
  9. Tumor Antigen3▲ 183×1 topic
  10. Monoclonal Antibodies2▲ 57×3 topics
  11. Glycosylation2▲ 35×2 topics
  12. Antibody Engineering1▲ 59×1 topic
  13. Fc Receptors1▲ 59×1 topic
  14. Therapeutic Antibodies1▲ 47×2 topics

Which research topics does TScan Therapeutics (United States) publish most on?

By volume in 2022-now: CAR-T cell therapy research, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research and Biosimilars and Bioanalytical Methods.

CAR-T cell therapy resea…8CAR-T cell therapy research: 8 fractional worksImmunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksBiosimilars and Bioanalytical Methods: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksVirus-based gene therapy research: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksHematopoietic Stem Cell Transplantation: 0 fractional worksT-cell and B-cell Immunology: 0 fractional works
OncologyImmunologyRadiology, Nuclear Medicine and ImagingMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 8 works
  2. 2 Immunotherapy and Immune Responses Immunology 2 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 0 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 0 works
  6. 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  7. 7 Virus-based gene therapy research Genetics 0 works
  8. 8 vaccines and immunoinformatics approaches Molecular Biology 0 works
  9. 9 Hematopoietic Stem Cell Transplantation Hematology 0 works
  10. 10 T-cell and B-cell Immunology Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available68.4%not open31.6%

World: 40% of research is openly available.

with international co-authors11.0%domestic only89.0%

World: 18% is written across borders.

How has TScan Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 215% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Waltham

All research institutions in Waltham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about TScan Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.